Form D · Other Health Care
AdherePlus, Inc.
Washington, DC · CIK 0002113859
Offering snapshot reported Mar 3, 2026 · SEC filing
- Reported sold
- $50K Offering amount: $15M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $50K Reported outside-investor minimum
- First sale
- Feb 15, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 3, 2026 | Initial | $50,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity, Debt
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $1.13M (estimated)
- Finders' fees
- $0
- Form D file number
- 021-575318
A maximum amount shown since the Issuer will pay a 7.5% sales commission on any equity financing and a 3.5% sales commission on any debt financing.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| US Capital Global | 000169544 |
Source: Form D, filed Mar 3, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| James Breidenstein | Director, Executive |
| Dan Cohen | Director, Executive |
| Peter Pitts | Director |
| Scott Sigman Md | Director |
| John Stineman | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
6218 Georgia Avenue No. 5080
Washington, DC, 20011
Washington, DC, 20011